Dr. Martens plc (LON:DOCS – Get Free Report)’s share price traded up 0.5% on Friday . The stock traded as high as GBX 74.95 ($0.93) and last traded at GBX 73.95 ($0.92). 1,003,337 shares were traded during trading, an increase of 27% from the average session volume of 792,198 shares. The stock had previously closed at GBX 73.55 ($0.91).
Dr. Martens Stock Performance
The company has a market capitalization of £711.19 million, a P/E ratio of 1,056.43, a PEG ratio of 6.40 and a beta of 0.11. The stock’s fifty day moving average price is GBX 65.38 and its 200-day moving average price is GBX 66.30. The company has a debt-to-equity ratio of 129.55, a quick ratio of 1.13 and a current ratio of 2.85.
Dr. Martens Cuts Dividend
The firm also recently disclosed a dividend, which will be paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th will be given a GBX 0.85 ($0.01) dividend. The ex-dividend date is Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens’s payout ratio is 4,285.71%.
Dr. Martens Company Profile
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Featured Articles
- Five stocks we like better than Dr. Martens
- Buy P&G Now, Before It Sets A New All-Time High
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- How to Buy Cheap Stocks Step by Step
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Technology Stocks Explained: Here’s What to Know About Tech
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.